Opinion · 22 Oct 2024
Research articlePublished 10 Jun 2021
Formulation, Development and Evaluation of Sustained Release Matrix Tablet of Antihypertensive Drugs
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
The current study was focus on to the formulation of sustain release tablet of Diltiazem. Diltiazem is calcium channel blocker was used for the treatment and management of high blood pressure, chronic stable angina. Diltiazem having the short half-life i.e., 3.0 to 4.5 hours and it is also having low bioavailability so that need to develops the controlled release tablet. The aim of this study was to provide sustained action, reduce the frequency of dose administration and increase bioavailability, reduce the dose dumping and increase patient compliance. Dry granulation method was used to the preparation of the matrix sustain release tablet. By using different polymers, the drug release extended up to the 24 hours. The drug-excipient compatibility study was done by using the FTIR studies. The evaluation of tablets was done by using various parameters like bulk density, tapped density, Angle of repose, Hauner’s ratio, Carr’s index, thickness, weight variation, friability, Disintegration and dissolution studies. The formulation F9 gives better result it release drug up to 24 hours.
Keywords
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in International Journal of Drug Development and Research.
Opinion · 22 Oct 2024
From Monoclonal Antibodies to CAR-T Therapy: Trends and Transformations in Cancer Treatment
Perspective · 21 Oct 2024
Natural Products in Drug Discovery: From Traditional Remedies to Modern Medicines
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalInternational Journal of Drug Development and Research
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Nikhil Arun Shete”
- BylineArticles whose byline prints “Vaijayanti Lokhande”
- BylineArticles whose byline prints “Pradnesh Mane”
- BylineArticles whose byline prints “Sachin Yelawande”
